Pharmaceutical Companies Wondering If They Should Develop Anti-Depressant Whose First Listed Side Effect Isn't 'SEVERE THOUGHTS OF SUICIDE'
Favicon 
babylonbee.com

Pharmaceutical Companies Wondering If They Should Develop Anti-Depressant Whose First Listed Side Effect Isn't 'SEVERE THOUGHTS OF SUICIDE'

U.S. — Researchers at the nation's leading pharmaceutical companies are reportedly having second thoughts about their manufacturing methods for antidepressants, wondering if perhaps they should come up with a pill whose first side effect isn't "severe thoughts of suicide".